BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
Business plan
1. MICRON
Business Plan on API Micronization unit.
Prepared by:
Chandni Patel(10BPH049)
Drashti Patel (10BPH051)
Dhara Patel (10BPH052)
Drashti Patel (10BPH054)
Hina Patel (10BPH056)
2. COMPANY INFORMATION
• “ MICRON” is a proposed Partnership firm which is
entering into the world of micronized active
pharmaceutical ingredient.
• The business project is intended to capitalize on the
increase in bioavailability of the drugs so they can get
absorbed easily and efficiently give its action.
• The project also helps the local formulation units to
produce the formulation with better effect.
2
3. Goal
Micron focuses on delivering innovative solutions to our
costumers. We facilitate sustainable returns and provide
a dynamic and challenging environment for all
stakeholders.
3
4. PRODUCTs AND BENEFITS
• CHLORZOXAZONE : It is a muscle relaxant drug which on
getting micronized gives a 35% increase in its
bioavailability.
• GLYBENCLAMIDE : It is used in the treatment of type 2
diabetes with the increased bioavailability by 17%.
• GLIMIPERIDE : It is an anti diabetic drug which on
Micronization gives 20% increase in bioavailability.
4
6. PROPOSED LOCATION
• Ankleshwar industrial estate.
• It is place in Bharuch.
• Pin code- 393002.
• It has good excess to many places as it is located near to the
NH 8.
• Availability of raw material and labour is good.
• Wide spread API manufacturing and utilizing unit.
6
7. PROMOTERS PROFILE
Name
Educational
Qualification
Percentage Partnership
Chandni B. Patel
(Financial Partner)
B Pharm 35%
Drashti N. Patel
(Financial Partner)
B Pharm 35%
Dhara H. Patel
(Technical Partner)
B Pharm 10%
Drashti R. Patel
(Technical Partner)
B Pharm 10%
Hina A. Patel
(Technical Partner)
B Pharm 10%
7
MICRON is a Partnership firm of 5 budding Entrepreneurs.
8. TYPE OF PROJECT
Small Scale Processing unit with an installed production capacity of:
• Mill size diameter 12”.
• Energy requirement :441.79 m3/hr.
• Capacity: 13- 113 Kg/hr.
8
9. Product Type & Quality
• We will offer the micro fine Chlorzoxazone, with
92% particles below 250 micron packed well in
fiber drum which shows the 35% increased
bioavailability.
• We offer the micro fine Glimepride, with 17%
better antidiabetic effect packed in a fiber drum.
• we offer the micron sized Glybenclamide, packed
in fiber drums with 20% increased bioavailability.
9
10. MAJOR CONSUMERS
Alpha Pharmaceutical
10
Genecia Health Care (Pvt.) Limited
Akums Drugs Pharmaceuticals Ltd.
(Alcare)
11. Marketing strategy
• The company produces the Micronized API lower than
the lowest price with High Quality material assured by
the reputed Quality Control Laboratories.
• Another thing is that the drug will be available in the
market as the company’s manufacturing unit is placed
nearby the National Highways and shipment is also
nearer.
• Company also accepts mailing orders and manufacture
according to International Requirements.
11
12. Technical knowhow available
• Today’s world has a great use of drugs but the great
problem with its bioavailability. Thus one of the
technique to increase the bioavailability is to do size
reduction (Micronization).
• We are using USDA-accepted design
MICRONIZER® JET MILL to get the well micronized
product.
12
14. Production process
14
Procure the API
Subject to milling in MICRONIZER®
JET MILL
Packing of material in fiber drum.
Sell the micronized API
15. Basis & Presumptions
• We can run single shifts for 225 days in 1st year.
• MICRONIZER® JET MILL can work at the rate of 13- 113
Kg/hr.
• Thus approx of 200 kg of product can be micronized in a
day excluding the time to wash the machine clean to
decrease contamination.
• Project time from site selection to trial run is 4-5
months.
15
16. Implementation Schedule
Selection of site, provisional
registration, project report
preparation
2 month
Sanction of loan 1 month
Selection of machinery 1 month
Commissioning and trial run 5 to 7 months
16
Actual Implementation time is 4-5 months due to overlapping of
activities
17. Production Schedule
Total Capacity 200 kg / day.
Capacity utilization
1st year 80 kg /day
2nd year 130 kg /day
3rd year 170 kg /day
17
18. Project details
LAND AND BUILDING COST
Sr. Particular
Area
Required
(m2) Rate Rs./m2 Total Value
1 Land 300 4000 1200000
2 Building 200 275 55000
Total Rs. 1255000
18
21. Misc Fixed Assets
Sr. No Particulars Total Value (Rs.)
1
Electrification and installation
@10%
38350
2
Office Furniture and
Equipments
50000
Total: 88350
21
22. Preliminary & Pre-Operative Expenses
Sr. No Particulars Amount (Rs.)
1 Establishment Expenses ( Tech.
Consultancy)
10000
2 Non refundable deposits & Start-Up
Expenses
25000
Total 35000
22
23. Total fixed cost
Cost Components Amount
Land & Building Cost 1255000
Equipment & Machinery 250600
Misc & Fixed Assets 88350
Preliminary & Preoperative
35000
Expenses
Total 1628950
23
24. Sales revenue
Sr no Items(s)
Quantity
Sold/Year
Rate per
kg(Rs)
Sales
Realization
(Rs)
1 Chlorzoxazone 8000 105 840000
2 Glybenclamide 2200 205 451000
3 Glimiperide 4500 155 697500
Total : 1988500
24
25. Raw Material (Monthly)
Sr. No Items(s) Quantity Rate (Rs) Total Value(Rs)
1 Chlorzoxazone 8000 97 776000
2 Glybenclamide 2200 200 440000
3 Glimiperide 4500 150 675000
25
26. Utilities (Monthly)
26
Sr. Particulars Expenditure (Rs)
1 Power/Electricity 2000
2 Water 1000
3 Fuel / compressed gas 4000
Total 7000
27. Manpower (Monthly)
Sr. no. Particulars No.
Wages/Salaries
per Month (Rs.)
Annual
Expenses (Rs)
1 Unskilled Person 3 1500 4500
2 Skilled Person 2 2800 5600
3 Operator 1 3500 3500
4 Shift Incharge 1 7000 7000
Total
7 Total 20600
27
32. Total cost of the project
Sr. no. Particulars Total Value (Rs.)
1 Fixed Capital 1628950
2 Working capital ( One Cycle ) 1917600
3
Preliminary & Pre-operative
Expenses
35000
Total 16720050
32
33. Means of Finance
Sr. No Particulars
Percentage of
loan
Amount (Rs.)
1
Own investment (Total)
60%
1150560
1st finance partner 500000
2nd finance partner 500000
1st thinking partner 50186
2nd thinking partner 50186
3rd thinking partner 50186
2 Term loan 40% 767040
Total: 1917600
33
34. Rate of return
• Rate of return in expected to be 1000 days (3 years
approx.)
34
35. SWOT Analysis
STRENGTHS
• It will provide new work
opportunities.
• Innovation in product.
• Low cost of innovation and
operation.
WEAKNESS
• Chances of failure.
• Unstable political situation.
• Stringent prize regulation
affecting the profitability of
pharma companies.
OPPORTUNITIES
• Many companies can not afford
this machinery but the use on
micronized product is must.
• Large demand for quality
services.
THREATS
• New emerging companies.
• Decrease in the use of
micronized product.
• Wages inflation.
35